Samidorphan

Samidorphan is a novel opioid system modulator, mainly acting as a μ-opioid receptor antagonist, with additional partial agonist activity at κ- and δ-opioid receptors. It is structurally related to naltrexone but has greater oral bioavailability and a longer elimination half-life (7–9 hours). Its therapeutic use is listed as alcohol dependence agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include samidorphanum and samidorfano. Its PubChem CID is 11667832.

CAS No 852626-89-2
Molecular Formula C21H26N2O4
Molecular Weight 370.4 g/mol
Synonyms (1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide

Frequently Asked Questions